Does Lactobacillus Rhamnosus Gut Randomized Trial work?

Updated October 2026

Quick Answer

Lactobacillus Rhamnosus Gut Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: In particular, in calorie-restricted rats fed 50% of the diet consumed by age-matched controls, mucous globules were found to be smaller, with a reduction in mucin proteins in the proximal and mid-intestinal segments [].

Key Takeaways

  • 01In particular, in calorie-restricted rats fed 50% of the diet consumed by age-matched controls, mucous globules were found to be smaller, with a reduction in mucin proteins in the proximal and mid-intestinal segments []. [Hatami Alireza (2026)]
  • 02Malnutrition-associated gut microbiome dysbiosis increases intestinal permeability due to disruptions in tight junction proteins, such as claudins, occludin, and zonula occludens-1. [Hatami Alireza (2026)]
  • 03Chronic inflammation has been implicated in the development of various metabolic disorders that can impair the body's ability to regulate energy utilization effectively and contribute to reduced food intake, muscle catabolism, and insulin resistance, promoting a catabolic state and weight loss overall [,]. [Hatami Alireza (2026)]
  • 04In 2022, an estimated 390 million adults worldwide were underweight due to malnourishment []. [Hatami Alireza (2026)]
The current Migaku evidence database contains 2 reusable source documents for Lactobacillus Rhamnosus Gut Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - In particular, in calorie-restricted rats fed 50% of the diet consumed by age-matched controls, mucous globules were found to be smaller, with a reduction in mucin proteins in the proximal and mid-intestinal segments []. [Hatami Alireza (2026); evidence level 2] - Malnutrition-associated gut microbiome dysbiosis increases intestinal permeability due to disruptions in tight junction proteins, such as claudins, occludin, and zonula occludens-1. [Hatami Alireza (2026); evidence level 2] - Chronic inflammation has been implicated in the development of various metabolic disorders that can impair the body's ability to regulate energy utilization effectively and contribute to reduced food intake, muscle catabolism, and insulin resistance, promoting a catabolic state and weight loss overall [,]. [Hatami Alireza (2026); evidence level 2] - In 2022, an estimated 390 million adults worldwide were underweight due to malnourishment []. [Hatami Alireza (2026); evidence level 2] - Dysbiosis can lead to the proliferation of harmful bacteria, increasing the risk of illnesses, such as bacterial vaginosis (BV), urinary tract infections (UTIs), and yeast infections (,). [Sahu Binaya Krushna (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. The effects of a novel combination of a probiotic supplement ( L. rhamnosus GG , L. acidophilus, and L. casei ) with a weight gain intervention on body composition, appetite, gut permeability, oxidative stress, and inflammation in underweight adults: study protocol for a double-blind, randomized controlled trial
  2. The role of probiotics in restoring and maintaining vaginal microbiome health: a review